Abstract
Obstructive sleep apnea syndrome (OSAS), combining nighttime occurring intermittent obstruction of upper airways with daytime somnolence, is associated with impairment in important mechanisms of cardiovascular regulation, in particular with neural and reflex mechanisms involved in blood pressure (BP) control. The resultant sympathetic activation and the associated metabolic and humoral responses lead to important autonomic and hemodynamic changes (vasoconstriction, fluid retention, elevated blood pressure and blood pressure variability, elevated heart rate, and reduced heart rate variability), which are not only present during the apneic episodes occurring at night but also during daytime wakefulness. The presence of all these conditions, the magnitude of which is directly associated to the severity of OSAS, not only promotes future development of hypertension but also makes hypertension occurring in OSAS more severe and resistant to antihypertensive treatment and associated with profound alterations in day-to-night BP changes. The evidence mentioned above highlights the relevance of OSAS as a risk condition not only for arterial hypertension but also for other cardiovascular diseases. This chapter is aimed at reviewing:
-
1.
The effects of OSAS on different mechanisms involved in integrated cardiovascular modulation (2) The resultant autonomic and hemodynamic responses to these alterations
-
2.
The epidemiological evidence supporting the association of elevated BP with OSAS
-
3.
The prognostic significance of OSAS-related hypertension
-
4.
The diagnostic approach to OSAS-related hypertension
-
5.
Finally, the role of pharmacological and non-pharmacological strategies on OSAS-related hypertension with emphasis on CPAP (i.e., which is known to be effective in reducing the sympathetic nervous system overdrive; a major contributing mechanism for OSAS-related alterations in BP regulation) and whether it may promote achievement of BP control and stabilization of BP levels for improving cardiovascular morbidity and mortality in OSAS patients
This is a preview of subscription content, log in via an institution.
References
Trzebski A (1992) Arterial chemoreceptor reflex and hypertension. Hypertension 19(6 Pt 1):562–566
Narkiewicz K, van de Borne PJ, Montano N et al (1998) Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97(10):943–945
Narkiewicz K, van de Borne PJ, Pesek CA et al (1999) Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99(9):1183–1189
Hedner JA, Wilcox I, Laks L et al (1992) A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis 146(5 Pt 1):1240–1245
Parati G, Di Rienzo M, Bonsignore MR et al (1997) Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 15(12 Pt 2):1621–1626
Narkiewicz K, Pesek CA, Kato M et al (1998) Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 32(6):1039–1043
Noda A, Nakata S, Koike Y et al (2007) Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res 30(8):669–676
Ryan S, Ward S, Heneghan C, McNicholas WT (2007) Predictors of decreased spontaneous baroreflex sensitivity in obstructive sleep apnea syndrome. Chest 131(4):1100–1107
Bonsignore MR, Parati G, Insalaco G et al (2002) Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 166(3):279–286
Lombardi C, Parati G, Cortelli P et al (2008) Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J Sleep Res 17(3):263–270
Somers VK, Dyken ME, Mark AL, Abboud FM (1993) Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328(5):303–307
Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904
Leroy M, Van Surell C, Pilliere R et al (1996) Short-term variability of blood pressure during sleep in snorers with or without apnea. Hypertension 28(6):937–943
Shiomi T, Guilleminault C, Sasanabe R et al (1996) Augmented very low frequency component of heart rate variability during obstructive sleep apnea. Sleep 19(5):370–377
Narkiewicz K, van de Borne PJ, Cooley RL et al (1998) Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98(8):772–776
Ali NJ, Davies RJ, Fleetham JA, Stradling JR (1992) The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest 101(6):1526–1532
Narkiewicz K, Kato M, Phillips BG et al (1999) Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100(23):2332–2335
Gonzaga CC, Gaddam KK, Ahmed MI et al (2010) Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 6(4):363–368
Pimenta E, Calhoun DA, Oparil S (2009) Sleep apnea, aldosterone, and resistant hypertension. Prog Cardiovasc Dis 51(5):371–380
Goodfriend TL, Calhoun DA (2004) Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43(3):518–524
Calhoun DA, Nishizaka MK, Zaman MA, Harding SM (2004) Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125(1):112–117
Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL et al (2007) Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 131(2):453–459
Calhoun DA (2010) Obstructive sleep apnea and hypertension. Curr Hypertens Rep 12(3):189–195
Dudenbostel T, Calhoun DA (2012) Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens 26(5):281–287
Gaddam K, Pimenta E, Thomas SJ et al (2010) Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 24(8):532–537
Kato M, Roberts-Thomson P, Phillips BG et al (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102(21):2607–2610
Ip MS, Tse HF, Lam B et al (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169(3):348–353
Jelic S, Lederer DJ, Adams T et al (2010) Vascular inflammation in obesity and sleep apnea. Circulation 121(8):1014–1021
Butt M, Khair OA, Dwivedi G et al (2011) Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea. Hypertension 58(3):417–424
Jelic S, Padeletti M, Kawut SM et al (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117(17):2270–2278
Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165(7):934–939
Minoguchi K, Yokoe T, Tazaki T et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):625–630
Phillips BG, Narkiewicz K, Pesek CA et al (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17(1):61–66
Kanagy NL, Walker BR, Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37(2 Part 2):511–515
Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112(17):2660–2667
Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462–2464
Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134
Ohga E, Nagase T, Tomita T et al (1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87(1):10–14
Doonan RJ, Scheffler P, Lalli M et al (2011) Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res 34(1):23–32
Tsioufis C, Thomopoulos K, Dimitriadis K et al (2007) The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J Hypertens 25(1):141–146
Drager LF, Bortolotto LA, Figueiredo AC et al (2007) Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 131(5):1379–1386
Shiina K, Tomiyama H, Takata Y et al (2006) Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertens Res 29(6):433–441
Nagahama H, Soejima M, Uenomachi H et al (2004) Pulse wave velocity as an indicator of atherosclerosis in obstructive sleep apnea syndrome patients. Intern Med 43(3):184–188
Kohler M, Pepperell JC, Casadei B et al (2008) CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 32(6):1488–1496
Drager LF, Bortolotto LA, Figueiredo AC et al (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712
Rasche K, Keller T, Tautz B et al (2010) Obstructive sleep apnea and type 2 diabetes. Eur J Med Res 15(Suppl 2):152–156
Basoglu OK, Sarac F, Sarac S et al (2011) Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thoracic Med 6(3):120–125
Zirlik S, Hauck T, Fuchs FS et al (2011) Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome. Med Sci Monit 17(3):CR159–CR164
Bonsignore MR, Esquinas C, Barcelo A et al (2012) Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J 39(5):1136–1143
Phillips BG, Kato M, Narkiewicz K et al (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279(1):H234–H237
Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25(6):1105–1187
Grote L, Hedner J, Peter JH (2000) Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 18(6):679–685
Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384
Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283(14):1829–1836
Coccagna G, Mantovani M, Brignani F et al (1972) Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) 8(5):1159–1172
Steinhorst AP, Goncalves SC, Oliveira AT et al (2014) Influence of sleep apnea severity on blood pressure variability of patients with hypertension. Sleep Breath 18(2):397–401
Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320(7233):479–482
Davies CW, Crosby JH, Mullins RL et al (2000) Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 55(9):736–740
Pankow W, Nabe B, Lies A et al (1997) Influence of sleep apnea on 24-hour blood pressure. Chest 112(5):1253–1258
Portaluppi F, Provini F, Cortelli P et al (1997) Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 15(11):1227–1233
Narkiewicz K, Montano N, Cogliati C et al (1998) Altered cardiovascular variability in obstructive sleep apnea. Circulation 98(11):1071–1077
Bixler EO, Vgontzas AN, Lin HM et al (2000) Association of hypertension and sleep-disordered breathing. Arch Intern Med 160(15):2289–2295
Duran J, Esnaola S, Rubio R, Iztueta A (2001) Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 163(3 Pt 1):685–689
Tanigawa T, Tachibana N, Yamagishi K et al (2004) Relationship between sleep-disordered breathing and blood pressure levels in community-based samples of Japanese men. Hypertens Res 27(7):479–484
Young T, Peppard P, Palta M et al (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157(15):1746–1752
Kiely JL, McNicholas WT (2000) Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16(1):128–313
Baguet JP, Hammer L, Levy P, Pierre H, Rossini E, Mouret S et al (2005) Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 23(3):521–527
Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP (1987) Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 16(2):235–251
Bramlage P, Pittrow D, Wittchen HU et al (2004) Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 17(10):904–910
O’Connor GT, Caffo B, Newman AB et al (2009) Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 179(12):1159–1164
Cano-Pumarega I, Duran-Cantolla J, Aizpuru F et al (2011) Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit Care Med 184(11):1299–1304
Somers VK, White DP, Amin R et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118(10):1080–1111
Calhoun DA, Jones D, Textor S et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51(6):1403–1419
Logan AG, Perlikowski SM, Mente A et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277
Hla KM, Young T, Finn L et al (2008) Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 31(6):795–800
Lavie-Nevo K, Pillar G (2006) Evening-morning differences in blood pressure in sleep apnea syndrome: effect of gender. Am J Hypertens 19(10):1064–1069
de la Sierra A, Segura J, Banegas JR et al (2011) Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57(5):898–902
Muxfeldt ES, Cardoso CR, Salles GF (2009) Prognostic value of nocturnal blood pressure reduction in resistant hypertension. Arch Intern Med 169(9):874–880
Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF (2003) Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 8(5):181–185
Barbe F, Duran-Cantolla J, Capote F et al (2010) Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 181(7):718–726
Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307(20):2161–2168
McNicholas WT, Bonsigore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156–178
Otto ME, Belohlavek M, Romero-Corral A et al (2007) Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 99(9):1298–1302
Tavil Y, Kanbay A, Sen N et al (2007) Comparison of right ventricular functions by tissue Doppler imaging in patients with obstructive sleep apnea syndrome with or without hypertension. Int J Card Imaging 23(4):469–477
Agrawal V, Vanhecke TE, Rai B et al (2009) Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron Clin Pract 113(3):c140–c147
Sim JJ, Rasgon SA, Derose SF (2010) Review article: managing sleep apnoea in kidney diseases. Nephrology (Carlton) 15(2):146–152
Yaggi HK, Concato J, Kernan WN et al (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041
Selim B, Won C, Yaggi HK (2010) Cardiovascular consequences of sleep apnea. Clin Chest Med 31(2):203–220
Gottlieb DJ, Yenokyan G, Newman AB et al (2010) Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122(4):352–360
Redline S, Yenokyan G, Gottlieb DJ et al (2010) Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 182(2):269–277
Capampangan DJ, Wellik KE, Parish JM et al (2010) Is obstructive sleep apnea an independent risk factor for stroke? A critically appraised topic. Neurologist 16(4):269–273
Marshall NS, Wong KK, Liu PY et al (2008) Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 31(8):1079–1085
Young T, Finn L, Peppard PE et al (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31(8):1071–1078
Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 57(6):1076–1080
Egan BM, Zhao Y, Axon RN et al (2011) Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 124(9):1046–1058
James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507–520
Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357
Wolf J, Hering D, Narkiewicz K (2010) Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res 33(9):867–871
Staessen JA, Thijs L, Fagard R et al (1999) Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 282(6):539–546
Sega R, Facchetti R, Bombelli M et al (2005) Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 111(14):1777–1783
Kikuya M, Ohkubo T, Asayama K et al (2005) Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 45(2):240–245
Fagard RH, Celis H, Thijs L et al (2008) Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51(1):55–61
Boggia J, Li Y, Thijs L et al (2007) Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370(9594):1219–1229
Hansen TW, Li Y, Boggia J, Thijs L et al (2011) Predictive role of the nighttime blood pressure. Hypertension 57(1):3–10
Clement DL, De Buyzere ML, De Bacquer DA et al (2003) Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 348(24):2407–2415
Fagard RH, Van Den Broeke C, De Cort P (2005) Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 19(10):801–807
Redon J, Campos C, Narciso ML et al (1998) Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 31(2):712–718
Dolan E, Stanton A, Thijs L et al (2005) Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46(1):156–161
Hansen TW, Jeppesen J, Rasmussen S et al (2005) Ambulatory blood pressure and mortality: a population-based study. Hypertension 45(4):499–504
Sander D, Kukla C, Klingelhofer J et al (2000) Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 102(13):1536–1541
Lurbe E, Redon J, Kesani A et al (2002) Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347(11):797–805
Metoki H, Ohkubo T, Kikuya M et al (2006) Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 47(2):149–154
Parati G, Lombardi C, Hedner J et al (2012) Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens 30(4):633–646
Parati G, Lombardi C, Hedner J et al (2013) Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 41(3):523–538
O’Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G et al (2003) European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 21(5):821–848. Epub 2003/04/26
Oikawa T, Obara T, Ohkubo T et al (2006) Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens 24(9):1737–1743
de la Sierra A, Banegas JR, Oliveras A et al (2012) Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens 30(6):1211–1216
Pickering TG, Davidson K, Gerin W, Schwartz JE (2002) Masked hypertension. Hypertension 40(6):795–796
Parati G, Ulian L, Santucciu C et al (1998) Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 31(5):1185–1189
Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF (2005) True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens 18(12 Pt 1):1534–1540
Oliveras A, Armario P, Hernandez-Del Rey R et al (2010) Urinary albumin excretion is associated with true resistant hypertension. J Hum Hypertens 24(1):27–33
Pierdomenico SD, Lapenna D, Bucci A et al (2005) Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 18(11):1422–1428
Salles GF, Cardoso CR, Muxfeldt ES (2008) Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 168(21):2340–2346
Cuspidi C, Macca G, Sampieri L et al (2001) High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 19(11):2063–2070
Moser M, Setaro JF (2006) Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med 355(4):385–392
Johansson K, Hemmingsson E, Harlid R et al (2011) Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study. BMJ 342:d3017
Yee BJ, Phillips CL, Banerjee D et al (2007) The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. Int J Obes 31(1):161–168
Pannain S, Mokhlesi B (2010) Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism. Best Pract Res Clin Endocrinol Metab 24(5):745–761
Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14):1724–1737
Leech JA, Onal E, Lopata M (1992) Nasal CPAP continues to improve sleep-disordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome. Chest 102(6):1651–1655
Kribbs NB, Pack AI, Kline LR et al (1993) Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 147(5):1162–1168
Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373(9657):82–93
Alajmi M, Mulgrew AT, Fox J et al (2007) Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 185(2):67–72
Haentjens P, Van Meerhaeghe A, Moscariello A et al (2007) The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167(8):757–764
Bazzano LA, Khan Z, Reynolds K, He J (2007) Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50(2):417–423
Becker HF, Jerrentrup A, Ploch T et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73
Logan AG, Tkacova R, Perlikowski SM et al (2003) Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 21(2):241–247
Dernaika TA, Kinasewitz GT, Tawk MM (2009) Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med 5(2):103–107
Lozano L, Tovar JL, Sampol G et al (2010) Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 28(10):2161–2168
Hu X, Fan J, Chen S et al (2015) The role of continuous positive airway pressure in blood pressure control for patients with obstructive sleep apnea and hypertension: a meta-analysis of randomized controlled trials. J Clin Hypertens (Greenwich) 17(3):215–222
Martinez-Garcia MA, Capote F, Campos-Rodriguez F et al (2013) Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 310(22):2407–2415
Muxfeldt ES, Margallo V, Costa LM et al (2015) Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension 65(4):736–742
Sekizuka H, Osada N, Akashi YJ (2016) Effect of oral appliance therapy on blood pressure in Japanese patients with obstructive sleep apnea. Clin Exp Hypertens 38(4):404–408
Andren A, Hedberg P, Walker-Engstrom ML et al (2013) Effects of treatment with oral appliance on 24-h blood pressure in patients with obstructive sleep apnea and hypertension: a randomized clinical trial. Sleep Breath 17(2):705–712
Iftikhar IH, Hays ER, Iverson MA et al (2013) Effect of oral appliances on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 9(2):165–174
Coruzzi P, Gualerzi M, Bernkopf E et al (2006) Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jaw-positioning appliance. Chest 130(5):1362–1368
White DP, Shafazand S (2013) Mandibular advancement device vs. CPAP in the treatment of obstructive sleep apnea: are they equally effective in Short term health outcomes? J Clin Sleep Med 9(9):971–972
DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77(1):75–197
Doumas M, Faselis C, Papademetriou V (2011) Renal sympathetic denervation in hypertension. Curr Opin Nephrol Hypertens 20(6):647–653
Schlaich MP, Sobotka PA, Krum H et al (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361(9):932–934
Witkowski A, Prejbisz A, Florczak E et al (2011) Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58(4):559–665
Ziegler MG, Milic M, Sun P (2011) Antihypertensive therapy for patients with obstructive sleep apnea. Curr Opin Nephrol Hypertens 20(1):50–55
Pimenta E, Calhoun DA (2010) Treatment of resistant hypertension. J Hypertens 28(11):2194–2195
Kasiakogias A, Tsioufis C, Thomopoulos C, Andrikou I, Aragiannis D, Dimitriadis K et al (2015) Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. J Hypertens 33(2):393–400
Kario K, Kuwabara M, Hoshide S et al (2014) Effects of nighttime single-dose administration of vasodilating vs sympatholytic antihypertensive agents on sleep blood pressure in hypertensive patients with sleep apnea syndrome. J Clin Hypertens (Greenwich) 16(6):459–466
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Parati, G., Lombardi, C., Narkiewicz, K., Wolf, J., Ochoa, J.E. (2018). Sleep Disturbances/Sleep Apnea. In: Berbari, A., Mancia, G. (eds) Disorders of Blood Pressure Regulation. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-59918-2_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-59918-2_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59917-5
Online ISBN: 978-3-319-59918-2
eBook Packages: MedicineMedicine (R0)